BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Jan 10, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Tacrolimus: Phase II data

Top-line data from an open-label Phase II trial in 58 patients showed that once-daily LCP-Tacro tablets demonstrated comparable tolerability to twice-daily Prograf tacrolimus capsules over 1 year. The...

Read the full 130 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >